Immediate Impact
1 by Nobel laureates 52 standout
Citing Papers
Prostate Cancer
2025 Standout
Circulating tumor cells: from new biological insights to clinical practice
2024 Standout
Works of Robert Zielinski being referenced
Updated overall survival outcomes in ENZAMET (ANZUP 1304), an international, cooperative group trial of enzalutamide in metastatic hormone-sensitive prostate cancer (mHSPC).
2022
Custirsen (OGX-011): A Second-Generation Antisense Inhibitor of Clusterin in Development for the Treatment of Prostate Cancer
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert Zielinski | 130 | 106 | 50 | 60 | 41 | 356 | |
| Osamu Kuwahara | 126 | 183 | 39 | 37 | 33 | 390 | |
| Richard A. Jacobson | 108 | 49 | 5 | 82 | 35 | 350 | |
| Melissa A. Frick | 155 | 162 | 59 | 41 | 33 | 376 | |
| Pedro A. Torres‐Saavedra | 79 | 74 | 20 | 27 | 29 | 304 | |
| Z Voboril | 70 | 104 | 20 | 67 | 38 | 306 | |
| Jianxing Li | 35 | 185 | 36 | 23 | 56 | 322 | |
| Yongqiang Yang | 69 | 57 | 34 | 97 | 42 | 378 | |
| Jason Hu | 34 | 100 | 32 | 38 | 25 | 392 | |
| Guowu Zhou | 72 | 126 | 46 | 91 | 28 | 317 | |
| Hanneke Meijer | 48 | 187 | 97 | 10 | 22 | 354 |
All Works
Login with ORCID to disown or claim papers
Loading papers...